Hedge Fund - Opaleye Management
Keros Therapeutics Inc. (KROS)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q4 (2024-12-31) | $0 | 0% | 0 | $51.97 |
| 2 | 2024 - Q3 (2024-09-30) | $22,953,677 | 3.82% | 395,276 | $49.39 |
| 3 | 2024 - Q2 (2024-06-30) | $16,794,750 | 3.83% | 367,500 | $53.73 |
| 4 | 2024 - Q1 (2024-03-31) | $24,328,500 | 5.3% | 367,500 | $59.30 |
| 5 | 2023 - Q4 (2023-12-31) | $14,214,200 | 3.77% | 357,500 | $31.36 |
| 6 | 2023 - Q3 (2023-09-30) | $11,489,552 | 3.73% | 360,400 | $37.33 |
| 7 | 2023 - Q2 (2023-06-30) | $14,169,477 | 3.38% | 352,650 | $43.84 |
| 8 | 2023 - Q1 (2023-03-31) | $10,162,600 | 3.04% | 238,000 | $50.51 |
| 9 | 2022 - Q4 (2022-12-31) | $11,428,760 | 3.97% | 238,000 | $46.71 |
| 10 | 2022 - Q3 (2022-09-30) | $12,087,000 | 4.99% | 321,300 | $34.66 |
| 11 | 2022 - Q2 (2022-06-30) | $7,626,000 | 3.43% | 276,000 | $43.88 |
| 12 | 2022 - Q1 (2022-03-31) | $14,451,000 | 4.48% | 265,750 | $51.33 |
| 13 | 2021 - Q4 (2021-12-31) | $15,549,000 | 3.29% | 265,750 | $49.87 |
| 14 | 2021 - Q3 (2021-09-30) | $13,945,000 | 2.6% | 352,500 | $35.59 |
| 15 | 2021 - Q2 (2021-06-30) | $9,980,000 | 1.65% | 235,000 | $54.17 |
| 16 | 2021 - Q1 (2021-03-31) | $9,694,000 | 1.42% | 157,500 | $63.36 |
The displayed share prices are average quarterly stock market prices.